Bictegravir Sodium | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Bictegravir Sodium
U.S. EXCLUSIVITIES

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Bictegravir Sodium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 6 USDMF, 1 EU WC, 2 KDMF, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

9 API Suppliers
6 USDMF
1 EU WC
2 KDMF
3 NDC API
5 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 2 FDA Orange Book, 1 Canada

3 FDF Dossiers
2 FDA Orange Book
1 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE

TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE
TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 17 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
17 NEWS #PharmaBuzz

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

22 US Patents, 8 US Exclusivities

22 US Patents
8 US Exclusivities

$ API Ref.Price (USD/KG) : 450 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

8 All

01 8GILEAD SCIENCES INC

filter Product Reset all filters

8 All

01 8BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

filter Exclusivity Expiration Date Reset all filters

8 All

01 12024-02-24

02 12026-06-18

03 22027-02-23

04 12027-04-24

05 12028-10-07

06 22031-02-23

filter Exclusivity Code Reset all filters

8 All

01 2I-942

02 1M-305

03 1M-82

04 1ODE-256

05 1ODE-378

06 2ODE-468

Product Main Page

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-378

Exclusivity Expiration Date

2028-10-07

Application Number

210251

Product Number

2

Exclusivity Details

01

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-378

Exclusivity Expiration Date : 2028-10-07

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-468

Exclusivity Expiration Date

2031-02-23

Application Number

210251

Product Number

1

Exclusivity Details

02

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-468

Exclusivity Expiration Date : 2031-02-23

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-942

Exclusivity Expiration Date

2027-02-23

Application Number

210251

Product Number

1

Exclusivity Details

03

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : I-942

Exclusivity Expiration Date : 2027-02-23

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-305

Exclusivity Expiration Date

2027-04-24

Application Number

210251

Product Number

1

Exclusivity Details

04

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : M-305

Exclusivity Expiration Date : 2027-04-24

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-82

Exclusivity Expiration Date

2024-02-24

Application Number

210251

Product Number

1

Exclusivity Details

05

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : M-82

Exclusivity Expiration Date : 2024-02-24

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-256

Exclusivity Expiration Date

2026-06-18

Application Number

210251

Product Number

1

Exclusivity Details

06

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-256

Exclusivity Expiration Date : 2026-06-18

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-468

Exclusivity Expiration Date

2031-02-23

Application Number

210251

Product Number

2

Exclusivity Details

07

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-468

Exclusivity Expiration Date : 2031-02-23

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-942

Exclusivity Expiration Date

2027-02-23

Application Number

210251

Product Number

2

Exclusivity Details

08

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

2024 ACI Convention

Not Confirmed

GILEAD SCIENCES INC

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : I-942

Exclusivity Expiration Date : 2027-02-23

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?